Laddar...
Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
The myelodysplastic syndromes (MDS) are a heterogeneous group of disorders that manifest as bone marrow failure with the risk of life threatening infections and bleeding. A third of these patients may transform to acute leukemia. Age and co-morbidities have limited treatment in the majority to suppo...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2006
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1936359/ https://ncbi.nlm.nih.gov/pubmed/18360650 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|